Short-term Rho-associated kinase inhibitor treatment accelerates primary keratinocyte growth while preserving stem cell characteristics
V. Jayarajan, G. T. Hall, T. Xenakis, N. Bulstrode, D. Moulding, S. Castellano, W.-L. Di
Short-term ROCKi treatment accelerates keratinocyte growth without compromising stem cell characteristics, suggesting a safe method for clinical applications.
bioRxiv · Jun 28, 2022Cell Biology